Fujifilm to transfer radiopharmaceutical business to PeptiDream

By NS Healthcare Staff Writer

03 Sep 21

Fujifilm Toyama Chemical’s radiopharmaceutical business will be succeeded by a new entity, formed through an absorption-type split

PharmaceuticalsContract Manufacturing

Fujifilm to invest additional $850m in FDB to expand capacity for biologics

By NS Healthcare Staff Writer

30 Jun 21

The investment will expand FDB’s capacity for recombinant vaccines and advanced gene therapies in the US and the…

PharmaceuticalsContract Manufacturing

Humanigen, Chime sign manufacturing deal for Covid-19 drug candidate lenzilumab

By NS Healthcare Staff Writer

17 May 21

Under the agreement, Chime Biologics will produce lenzilumab bulk drug substance and drug product for Humanigen for commercial…

PharmaceuticalsContract Manufacturing

Eli Lilly inks licensing deal with Cipla, Sun and Lupin for Covid-19 drug Baricitinib

By NS Healthcare Staff Writer

11 May 21

Baricitinib, a once-daily, oral medication was discovered by US-based Incyte and licensed to Eli Lilly

PharmaceuticalsContract Manufacturing

Fujifilm chooses North Carolina for its new CDMO facility

By NS Healthcare Staff Writer

19 Mar 21

The new large-scale cell culture manufacturing facility in Holly Springs, North Carolina will create 725 jobs in the…

PharmaceuticalsContract Manufacturing

Takeda, IDT to support manufacturing of Janssen’s Covid-19 vaccine

By NS Healthcare Staff Writer

16 Mar 21

Takeda will use the IDT’s capacity, previously reserved for its dengue vaccine candidate (TAK-003), to produce Janssen’s Covid-19…

PharmaceuticalsContract Manufacturing

Thermo Fisher acquires Novasep’s viral vector manufacturing business

By NS Healthcare Staff Writer

18 Jan 21

With the acquisition, Thermo Fisher will expand its manufacturing capabilities for cell and gene therapies

PharmaceuticalsContract Manufacturing

Novartis collaborates with BeiGene for cancer drug tislelizumab

By NS Healthcare Staff Writer

12 Jan 21

The collaboration will help Novartis expand its oncology portfolio with late-stage PD-1 for monotherapy and potential PD-1 combinations

PharmaceuticalsContract Manufacturing

Merck acquires mRNA-based contract manufacturer AmpTec

By NS Healthcare Staff Writer

08 Jan 21

The acquisition of AmpTec will allow Merck to strengthen its capabilities in developing and manufacturing mRNA, used in…

PharmaceuticalsContract Manufacturing

Fujifilm to invest $2bn to build new biopharmaceutical manufacturing site in US

By NS Healthcare Staff Writer

07 Jan 21

The new manufacturing site for biopharmaceuticals will offer an end-to-end single-site solution from drug substances to fill-finish and…

PharmaceuticalsContract Manufacturing